Mesenchymal Stem Cells for Frailty Syndrome
Clinical trial NCT06501066 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT06501066
- Sponsor
- Meribank Biotech Co., Ltd.
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Phase 1, Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-06-03
- Primary completion
- 2026-12-01
- Enrollment
- 66
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.